Posted originally on CTH on October 16, 2025 | Sundance 

President Trump makes announcements on pharmaceutical products and healthcare benefit costs – as it relates to IVF treatments.  Additionally, President Trump takes questions on a variety of issues from the Oval Office.

WASHINGTON ‒ President Donald Trump announced a plan aimed at expanding access to in vitro fertilization, seeking to fulfill a 2024 campaign promise by launching a new effort to lower IVF costs for families.

Trump’s plan, which he unveiled Oct. 17 in the Oval Office, also calls for eliminating red tape for employers who want to expand access for the millions of Americans who want coverage for the procedure. Yet it would not mandate that insurers cover IFV services, a proposal he campaigned on.

Under the deal, EMD Serono, the largest fertility drug manufacturer in the United States, has agreed to lower prices of medications between 42% to 79% under a most-favored nation pricing agreement. Trump said that includes lowering prices for Gonal-f, a drug that stimulates the ovary to produce healthy eggs.

The medication will be available via TrumpRx, the website to allow direct-to-consumers sales of some prescription drugs, in early 2026. The amount of the discount will be based on the patient’s income.

“There’s no deeper happiness and joy than raising children, and now millions of Americans struggling with infertility will have a new chance to share the greatest experience of them all,” Trump said. (read more)

.

.